Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of CACNA1G mRNA | decreases expression | 19933214
|
D000487 |
Allethrin |
Allethrin inhibits the reaction [CACNA1G protein results in increased transport of Calcium] | decreases reaction|increases transport | 14634047
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CACNA1G mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in decreased expression of CACNA1G mRNA | decreases expression | 16715494
|
D001464 |
Barium |
CACNA1G mRNA alternative form results in increased transport of Barium | increases transport | 11179973
|
D001464 |
Barium |
CACNA1G protein results in increased transport of Barium | increases transport | 12163980
|
D001464 |
Barium |
Cerium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D001464 |
Barium |
Erbium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D001464 |
Barium |
Gadolinium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D001464 |
Barium |
Holmium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D001464 |
Barium |
Lanthanum inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D001464 |
Barium |
Neodymium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D001464 |
Barium |
Scandium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D001464 |
Barium |
Ytterbium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D001464 |
Barium |
Yttrium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D002118 |
Calcium |
CACNA1G protein results in increased transport of Calcium | increases transport | 10734232
|
D002118 |
Calcium |
CACNG2 protein affects the reaction [CACNA1G protein results in increased transport of Calcium] | affects reaction|increases transport | 10734232
|
D002118 |
Calcium |
CACNG4 protein affects the reaction [CACNA1G protein results in increased transport of Calcium] | affects reaction|increases transport | 10734232
|
D002118 |
Calcium |
CACNG5 protein affects the reaction [CACNA1G protein results in increased transport of Calcium] | affects reaction|increases transport | 10734232
|
D002118 |
Calcium |
Allethrin inhibits the reaction [CACNA1G protein results in increased transport of Calcium] | decreases reaction|increases transport | 14634047
|
D002118 |
Calcium |
CACNA1G protein results in increased transport of Calcium | increases transport | 14634047 11073957
|
D002563 |
Cerium |
Cerium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D003609 |
Dactinomycin |
Dactinomycin inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA] | decreases reaction|increases expression | 19292980
|
D004871 |
Erbium |
Erbium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of CACNA1G mRNA | affects cotreatment|decreases expression | 17404688
|
D004958 |
Estradiol |
Estradiol results in increased expression of CACNA1G mRNA | increases expression | 20068009
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of CACNA1G mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CACNA1G mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CACNA1G mRNA | affects cotreatment|increases expression | 17942748
|
D005576 |
Forskolin |
Mibefradil inhibits the reaction [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein] | affects cotreatment|decreases reaction|increases activity | 17110049
|
D005576 |
Forskolin |
Nickel inhibits the reaction [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein] | affects cotreatment|decreases reaction|increases activity | 17110049
|
D005682 |
Gadolinium |
Gadolinium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D006695 |
Holmium |
Holmium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D015056 |
1-Methyl-3-isobutylxanthine |
Mibefradil inhibits the reaction [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein] | affects cotreatment|decreases reaction|increases activity | 17110049
|
D015056 |
1-Methyl-3-isobutylxanthine |
Nickel inhibits the reaction [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein] | affects cotreatment|decreases reaction|increases activity | 17110049
|
D007811 |
Lanthanum |
Lanthanum inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D020748 |
Mibefradil |
Mibefradil inhibits the reaction [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein] | affects cotreatment|decreases reaction|increases activity | 17110049
|
D009354 |
Neodymium |
Neodymium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D009532 |
Nickel |
Nickel inhibits the reaction [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1G protein] | affects cotreatment|decreases reaction|increases activity | 17110049
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [telmisartan results in decreased expression of CACNA1G mRNA] | decreases expression|decreases reaction | 19292980
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of CACNA1G mRNA | affects cotreatment|decreases expression | 17404688
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [telmisartan results in decreased expression of CACNA1G mRNA] | decreases expression|decreases reaction | 19292980
|
D012538 |
Scandium |
Scandium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of CACNA1G mRNA | affects expression | 17555576
|
C084178 |
telmisartan |
PD 98059 inhibits the reaction [telmisartan results in decreased expression of CACNA1G mRNA] | decreases expression|decreases reaction | 19292980
|
C084178 |
telmisartan |
SB 203580 inhibits the reaction [telmisartan results in decreased expression of CACNA1G mRNA] | decreases expression|decreases reaction | 19292980
|
C084178 |
telmisartan |
telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1G mRNA] | decreases reaction|increases expression | 19292980
|
C084178 |
telmisartan |
telmisartan results in decreased expression of CACNA1G mRNA | decreases expression | 19292980
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CACNA1G mRNA | affects cotreatment|increases expression | 17942748
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of CACNA1G mRNA | increases expression | 19101580
|
D015018 |
Ytterbium |
Ytterbium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
D015019 |
Yttrium |
Yttrium inhibits the reaction [CACNA1G protein results in increased transport of Barium] | decreases reaction|increases transport | 12163980
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.28 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.44 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.44 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.69 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.30 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.68 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
4.34 | 16166738 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
3.99 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
3.99 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.12 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.97 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.72 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.37 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.21 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.50 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.03 | 18316065 18558336 18177632 17507914 17157402 19232924 16609825 19460635 17688650 18940202 18775368 15238991 18985861 20603192 18396377 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.94 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.81 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.52 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.47 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.47 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Dactinomycin |
5.27 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.07 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.00 | 15845082 15665606 15380490 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.26 | 12948864 17018787 16675129 14630087 17289903 19861407 18497071 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
2.26 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.26 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.26 | 17440819 16818667 15565566 18425577 19189210 20859285 19221464 19066611 19410462 19288272 18855134 20065188 18351453 17242785 19142967 19289846 15668708 21152245 18815881 17261762 17049068 18984771 19189212 19200415 21138602 20005174 19115204 16873071 17893378 18997820 19487384 18821012 19011961 20390343 20544844 16202921 19084267 11161223 19155303 19059307 20135344 19244106 19103187 18629630 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.26 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.20 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.59 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.25 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
2.85 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
2.85 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.39 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.22 | 18850075 16120746 18670907 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.60 | 18566989 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.61 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.94 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.68 | 17110522 17681005 15861022 16919318 11677210 16105132 17333356 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.99 | 16354765 15340226 8697196 12621046 15668235 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.39 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.39 | 16575769 8888407 17688650 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.10 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
3.70 | 17244072 19470301 17100760 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
4.39 | 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.61 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
8.11 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
8.11 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.23 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.51 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
3.51 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.57 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.81 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.15 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.64 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
13.87 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
13.87 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
13.87 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.82 | 19148513 18566989 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.82 | 20544844 19155303 17893378 16202921 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.17 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.17 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.90 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.65 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.80 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.37 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.04 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.80 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.82 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
11.75 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
11.75 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
11.75 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.08 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.20 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.62 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.88 | 18558336 8888407 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.26 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.92 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.69 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.33 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.19 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.10 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.64 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.76 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.68 | 17263646 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.49 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.60 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.78 | 16354765 18606429 8697196 16959395 15340226 |
MESH:D006973 |
Hypertension |
|
telmisartan |
5.48 | 16077267 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.48 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.55 | 16569931 16945680 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.18 | 18306037 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.14 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.22 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.32 | 17937319 |
MESH:D007249 |
Inflammation |
|
Nickel |
10.87 | 16166738 |
MESH:D007249 |
Inflammation |
|
Progesterone |
10.87 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
10.87 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.87 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.80 | 16627594 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.10 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.18 | 18306037 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.44 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.69 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
6.69 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.78 | 16316344 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
4.97 | 16972261 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.11 | 17596541 16294345 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.97 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.25 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.25 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.25 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
4.06 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.06 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
1.95 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.00 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.17 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.17 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.50 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.00 | 16891317 11807958 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
9.00 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.00 | 16827153 14580682 19196722 11731420 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.76 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.76 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.85 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.92 | 15990972 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.01 | 18765137 18803445 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.25 | 1613127 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.79 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.01 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.81 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.08 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.44 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.43 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.73 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.47 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.63 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.63 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
2.96 | 8888407 16359493 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.62 | 17882678 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.59 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.59 | 16525653 17393432 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.44 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.98 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.31 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.59 | 11118676 11222880 11896295 11399792 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
8.59 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.65 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.27 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.27 | 15067354 |
MESH:D011507 |
Proteinuria |
|
telmisartan |
5.36 | 16077267 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.05 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.27 | 11422049 12752131 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.59 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.93 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.76 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Dactinomycin |
4.83 | 14601052 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.03 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.57 | 14763951 17978042 11044598 15475178 1511512 16876388 3137016 11738929 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.92 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.67 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.67 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
9.99 | 15862959 16503802 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
9.99 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.58 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.27 | 12833885 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.38 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.93 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.64 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.42 | 19048282 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.97 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.26 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
2.26 | 17572228 16712894 8653321 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.38 | 8888407 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.05 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.33 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.30 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.98 | 15886252 |